- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Rheumatoid Arthritis
The Rheumatology Network rheumatoid arthritis clinical focus page provides information on the latest rheumatoid arthritis news, study and clinical trial findings, and clinical guideline updates. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for rheumatoid arthritis drugs.
Elevated Immune Response to Gut Bacterial Protein Associated with Rheumatoid Arthritis
October 26, 2022
Patients with rheumatoid arthritis had significantly higher levels of IgA anti-Pc-p27 antibodies and higher levels of IgG anti-Pc-p27 antibodies when compared with healthy controls.
John Cush, MD: Rheumatology Year in Review
October 24, 2022
John Cush, MD, discusses his CCR West presentation “Rheumatology Year in Review: 2022.”
John Cush, MD: How Early is Too Early to Diagnose and Treat Rheumatoid Arthritis?
October 21, 2022
John Cush, MD, discusses his presentation “Rheumatoid Arthritis: How Early is Too Early to Diagnose and Treat?”
Concomitant Methotrexate Linked to Reduced Efficacy of COVID-19 Booster Dose in Elderly Patients with RA
October 17, 2022
Recent findings suggest that methotrexate reduces humoral vaccination response against COVID-19 in older, but not younger, patients with rheumatoid arthritis.
Rheumatology Network's Top 5: October 15, 2022
October 15, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending October 15, 2022.
Filgotinib Plus Methotrexate Improves Disease Activity, Functional Measures in MTX-IR RA
October 14, 2022
“Failed or inadequate response to disease-modifying antirheumatic drugs (DMARDs) is associated with poor prognosis," investigators noted.
Ozoralizumab Effectively Treats Active RA Without Methotrexate Co-Therapy
October 11, 2022
The study examined ozoralizumab without concomitant therapy, as methotrexate cannot be given to all patients with rheumatoid arthritis due to inadequate efficacy and tolerability.
Higher Prevalence of Sarcopenia Reported in Patients with Rheumatoid Arthritis
October 06, 2022
The single-center, cross-sectional study assessed chair rise time, gait speed, and grip strength to determine the prevalence of sarcopenia.
Multibiomarker Disease Activity Scores Support Assessment of Biosimilarity in RA
October 05, 2022
This MBDA score has been validated to correlate with the disease activity score, including a 28-joint count and CRP (DAS28-CRP), in patients with rheumatoid arthritis.
Pirfenidone Slows Decline of Forced Vital Capacity in RA-Associated Interstitial Lung Disease
September 26, 2022
Although results are promising, findings should be interpreted with caution, as the study was underpowered and terminated early due to the COVID-19 pandemic.